These two mAbs protected K18-hACE2 mice from lethal viral infection in the face of SARS-CoV-2 WT or Delta (B.1.617.2) challenge, and 7B3 also showed therapeutic activity against lethal Omicron infection in vivo. This evidence concerns the gene KRT18 and viral infectious disease.